Methylmalonic acid--an endogenous toxin?

S Kölker1, J G Okun

  • 1Department of General Pediatrics, Division of Inborn Metabolic Diseases, University Children's Hospital, Im Neuenheimer Feld 150, 69120, Heidelberg, Germany. Stefan.Koelker@med.uni-heidelberg.de

Insights

Methylmalonic acidurias may involve other metabolites, not just methylmalonic acid, in causing neurological damage. Further research is needed to determine methylmalonic acid's role in kidney complications associated with these conditions.

Area of Science:

  • Biochemistry
  • Metabolic disorders
  • Neuroscience

Background:

  • Methylmalonic acid was historically viewed as the primary neurotoxin in methylmalonic acidurias.
  • Recent research suggests other propionyl-coenzyme A metabolites contribute to neuropathogenesis through synergistic mitochondrial energy metabolism inhibition.

Purpose of the Study:

  • To investigate the role of methylmalonic acid in the development of chronic renal failure in methylmalonic acidurias.
  • To explore potential alternative mechanisms beyond direct toxicity in the organ manifestations of methylmalonic acidurias.

Main Methods:

  • Analysis of metabolite profiles in patients with methylmalonic acidurias.
  • In vitro studies assessing the impact of methylmalonic acid and related metabolites on renal cell function.
  • Comparative studies examining neurological and renal outcomes in relation to metabolite levels.

Main Results:

  • Evidence suggests that metabolites other than methylmalonic acid are key drivers of neurological impairment in methylmalonic acidurias.
  • The specific role of methylmalonic acid in the pathogenesis of chronic kidney disease in these disorders remains to be elucidated.
  • Synergistic effects of propionyl-coenzyme A derivatives on mitochondrial function are critical for understanding disease mechanisms.

Conclusions:

  • The understanding of methylmalonic acidurias' pathogenesis is shifting from methylmalonic acid as the sole neurotoxin to a broader consideration of co-metabolites.
  • Further investigation is required to clarify the contribution of methylmalonic acid to renal manifestations, particularly chronic renal failure.

Related Concept Videos

Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives01:35

Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives

Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Alkylation of β-Diester Enolates: Malonic Ester Synthesis01:14

Alkylation of β-Diester Enolates: Malonic Ester Synthesis

Malonic ester synthesis is a method to obtain α substituted carboxylic acids from ꞵ-diesters such as diethyl malonate and alkyl halides.
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...